A detailed history of Townsquare Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Townsquare Capital LLC holds 134,964 shares of GILD stock, worth $12.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
134,964
Previous 117,968 14.41%
Holding current value
$12.1 Million
Previous $8.09 Million 39.78%
% of portfolio
0.14%
Previous 0.11%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $1.13 Million - $1.43 Million
16,996 Added 14.41%
134,964 $11.3 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $45,657 - $52,692
723 Added 0.62%
117,968 $8.09 Million
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $1.47 Million - $1.79 Million
-20,535 Reduced 14.9%
117,245 $8.59 Million
Q4 2023

Feb 15, 2024

BUY
$73.27 - $83.09 $4.55 Million - $5.16 Million
62,052 Added 81.94%
137,780 $11.2 Million
Q3 2023

Nov 15, 2023

BUY
$73.94 - $80.67 $465,378 - $507,736
6,294 Added 9.06%
75,728 $5.68 Million
Q2 2023

Nov 13, 2023

BUY
$76.01 - $86.7 $397,380 - $453,267
5,228 Added 8.14%
69,434 $5.35 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $153,151 - $174,486
1,981 Added 3.18%
64,206 $5.33 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $772,144 - $1.11 Million
-12,390 Reduced 16.61%
62,225 $5.34 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $53,109 - $60,664
892 Added 1.21%
74,615 $4.6 Million
Q2 2022

Aug 08, 2022

BUY
$57.72 - $65.01 $150,245 - $169,221
2,603 Added 3.66%
73,723 $4.56 Million
Q1 2022

Apr 28, 2022

BUY
$57.92 - $72.58 $359,277 - $450,213
6,203 Added 9.56%
71,120 $4.23 Million
Q4 2021

Feb 11, 2022

SELL
$64.88 - $73.64 $828,777 - $940,677
-12,774 Reduced 16.44%
64,917 $4.71 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $503,613 - $543,343
7,440 Added 10.59%
77,691 $5.43 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $583,987 - $638,089
9,201 Added 15.07%
70,251 $4.81 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $889,440 - $1.01 Million
14,824 Added 32.07%
61,050 $3.95 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $845,444 - $963,344
14,924 Added 47.68%
46,226 $2.69 Million
Q3 2020

Dec 01, 2020

BUY
$62.1 - $78.08 $149,909 - $188,485
2,414 Added 8.36%
31,302 $1.96 Million
Q2 2020

Aug 17, 2020

BUY
$72.34 - $84.0 $1.85 Million - $2.15 Million
25,617 Added 783.15%
28,888 $2.22 Million
Q1 2020

May 18, 2020

SELL
$62.63 - $80.22 $22,108 - $28,317
-353 Reduced 9.74%
3,271 $262,000
Q4 2019

May 18, 2020

SELL
$61.62 - $67.78 $2,156 - $2,372
-35 Reduced 0.96%
3,624 $235,000
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $17,565 - $19,389
-281 Reduced 7.13%
3,659 $234,000
Q2 2019

Aug 15, 2019

SELL
$61.87 - $69.38 $728,519 - $816,949
-11,775 Reduced 74.93%
3,940 $256,000
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $752,798 - $843,331
12,039 Added 327.5%
15,715 $1.02 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $222,545 - $290,404
3,676 New
3,676 $249,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.